KRAS

You have access
Prediction System for KRAS Mutation Detection in Circulating Tumor DNA in Unresectable Pancreatic Cancer
HIROSHI SHIMIZU, REI SUZUKI, HIROYUKI ASAMA, MITSURU SUGIMOTO, KENTARO SATO, KENTO OSAWA, REI OHIRA and HIROMASA OHIRA

Anticancer Research September 2025, 45 (9) 3931-3938; DOI: https://doi.org/10.21873/anticanres.17751
Open Access
3D-floating Culture for Cancer Research: A Mini-review
AKIKO FUKUYAMA, TAKANORI KITAGUCHI, KAZUMASA YOSHIDA, TAICHI MATSUMOTO, KAZUHIRO KOIKAWA, MICHITAKA NAKANO, GEN MARUTA, HISANORI MAEOKA, SHUHEI ISHIKURA, SENJI SHIRASAWA and TOSHIYUKI TSUNODA

Anticancer Research August 2025, 45 (8) 3401-3408; DOI: https://doi.org/10.21873/anticanres.17702
You have access
Analysis of Methylation of Tumor-suppressive miRNAs and KRAS/TP53 Mutations in Pancreatic Juice
KOUSHIRO OHTSUBO, KUNIO MIYAKE, SHIGEKI SATO, HIROYUKI SAKAGUCHI, KOJI FUKUDA, HIROSHI KOTANI, AKIHIRO NISHIYAMA, SHIGEKI NANJO, KANAME YAMASHITA, SHINJI TAKEUCHI, SEIJI YANO, SAWAKO KURUMA, JUN NAKAHODO, MASATAKA KIKUYAMA and HIROAKI TANIGUCHI

Anticancer Research December 2024, 44 (12) 5253-5261; DOI: https://doi.org/10.21873/anticanres.17353
You have access
CX-4945 (Silmitasertib) Induces Cell Death by Impairing Lysosomal Utilization in KRAS Mutant Cholangiocarcinoma Cell Lines
DA SOL LEE, MIN WOO HAN, YONGHYUN KANG, CHORONG KIM, SEONMIN LEE, KYU-PYO KIM and CHANGHOON YOO

Anticancer Research May 2024, 44 (5) 1939-1946; DOI: https://doi.org/10.21873/anticanres.16996
You have access
PHRF1 Promotes Cell Invasion by Modulating SOX4 Expression in Colorectal Cancer HCT116-p53^−/− Cells
HUNG-WEI LIN, TING-WEI SHIH, ADAOBI AMANNA and MAU-SUN CHANG

Anticancer Research December 2023, 43 (12) 5437-5446; DOI: https://doi.org/10.21873/anticanres.16747
Open Access
Cetuximab Enhances the Efficacy of MRTX1133, a Novel KRAS^G12D Inhibitor, in Colorectal Cancer Treatment
MASAHIRO KATAOKA, MASATO KITAZAWA, SATOSHI NAKAMURA, MAKOTO KOYAMA, YUTA YAMAMOTO, SATORU MIYAZAKI, NAO HONDO, HIROKAZU TANAKA and YUJI SOEJIMA

Anticancer Research October 2023, 43 (10) 4341-4348; DOI: https://doi.org/10.21873/anticanres.16629
Open Access
Prognostic Value of KRAS Exon-specific Mutations in Patients With Colorectal Cancer
KENTARO ASAKO, TAMURO HAYAMA, YOJIRO HASHIGUCHI, TOSHIYA MIYATA, YOSHIHISA FUKUSHIMA, RYU SHIMADA, KENSUKE KANEKO, KEIJIRO NOZAWA, KEIJI MATSUDA and TAKEO FUKAGAWA

Anticancer Research April 2023, 43 (4) 1563-1568; DOI: https://doi.org/10.21873/anticanres.16306
Open Access
Cancer Spheroid Proliferation Is Suppressed by a Novel Low-toxicity Compound, Pyra-Metho-Carnil, in a Context-independent Manner
KAZUMASA YOSHIDA, KENSUKE NISHI, SHUHEI ISHIKURA, KAZUHIKO NAKABAYASHI, RYO YAZAKI, TAKASHI OHSHIMA, MASAHIKO SUENAGA, SENJI SHIRASAWA and TOSHIYUKI TSUNODA

Anticancer Research August 2022, 42 (8) 3993-4001; DOI: https://doi.org/10.21873/anticanres.15895
You have access
Growth Suppression of Cancer Spheroids With Mutated KRAS by Low-toxicity Compounds from Natural Products
SAYURI HASHIMOTO, MASAYOSHI NAGAI, KENSUKE NISHI, SHUHEI ISHIKURA, KAZUHIKO NAKABAYASHI, RYO YAZAKI, TAKASHI OHSHIMA, MASAHIKO SUENAGA, SENJI SHIRASAWA and TOSHIYUKI TSUNODA

Anticancer Research August 2021, 41 (8) 4061-4070; DOI: https://doi.org/10.21873/anticanres.15207
You have access
Radiogenomic and Deep Learning Network Approaches to Predict KRAS Mutation from Radiotherapy Plan CT
BUM-SUP JANG, CHANGHOON SONG, SUNG-BUM KANG and JAE-SUNG KIM

Anticancer Research August 2021, 41 (8) 3969-3976; DOI: https://doi.org/10.21873/anticanres.15193

Main menu

User menu

Search

KRAS

Pages